Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

Pediatric Inpatient Psychiatry Units Effective In Treating Adolescent Patients With Severe Mental Illness, Study Finds

Healio (5/23, Mahoney) reported a study found that “adolescents with mental health issues who were admitted to a pediatric inpatient psychiatry unit experienced significant improvements in depression, suicidal thoughts and behaviors, and anxiety.” Researchers observed “that the patients experienced improvements in all the measured outcomes from admission to discharge.” They saw a “large effect size for depression as per” the Quick Inventory of Depressive Symptomatology Adolescent 17‐item Self‐Report and “a moderate effect size for emotional regulation as per” the Difficulties in Emotion Regulation Scale Short Form. In addition, they “observed smaller effect sizes” for anxiety, quality of life, and family functioning. The study was published in Psychiatric Research & Clinical Practice

Related Links:

— “Pediatric inpatient psychiatry units effective for adolescents with severe mental illness,” Moira Mahoney, Healio, May 23, 2025

Digital Technology Use Linked To Reduced Cognitive Decline Risk In Patients Middle-Aged And Older, Review Finds

The Washington Post (5/26, McMahan) reports a systemic review found that “engagement with digital technology was associated with a 58 percent reduced risk of cognitive impairment in people middle-aged and older.” The researchers reviewed 57 studies involving more than 411,000 adults with an average age of 69 to determine “whether exposure to technology has helped or harmed cognition among the first generation of adults with prolonged exposure to digital devices such as smartphones, tablets and computers.” They observed that “technology could play a role in preserving brain function, not worsening.” Researchers concluded, “There was no credible evidence from the longitudinal studies, or the meta-analysis as a whole, for widespread digital ‘brain drain’ or ‘digital dementia’ as a result of general, natural uses of digital technology.” The review was published in Nature Human Behavior.

Related Links:

— “The Washington Post (requires login and subscription)

GLP-1 Agonists May Help Prevent Weight Gain In Patients Trying To Quit Smoking, Review Finds

MedPage Today (5/21, Susman) reports a systematic review and meta-analysis of three randomized trials presented at the American Psychiatric Association annual meeting found that “for people trying to quit smoking, use of a GLP-1 receptor agonist may help prevent weight gain, a common barrier to quitting.” Researchers observed that “between 168 patients in the GLP-1 agonist groups and 169 control patients, the mean difference in post-cessation weight gain was -2.59 kg. However, the difference between groups in abstinence rates was not significantly different.” They noted that “experimental data suggest that GLP-1 receptor agonists, traditionally used for type 2 diabetes and obesity, may have a role in the pathophysiology of addiction, but its efficacy in nicotine abstinence remains unknown.” However, they could not “definitively say that using GLP-1s will help people stop smoking.”

Related Links:

MedPage Today (requires login and subscription)

Use Of Chemical Restraint More Common Among Black Patients In Psychiatric Emergency Settings, Study Suggests

MedPage Today (5/21, Susman) reports a study presented at the American Psychiatric Association annual meeting suggests the “use of chemical restraint was more common among Black patients versus white and Hispanic patients in psychiatric emergency settings.” Researchers observed that “among 852 patients, chemical restraint – intramuscular injections of drugs such as benzodiazepines or antipsychotics – was used in 37.7% of Black patients compared with 32.6% of white patients and 22.6% of Hispanic patients, with the latter difference reaching statistical significance.” They concluded, “These findings suggest disparities in care and the need for further research to determine how these data impact patient outcomes and mental health care-seeking behavior. Disproportionate use of chemical restraint can result in adverse clinical outcomes, including prolonged hospitalization and higher readmission rates.”

Related Links:

MedPage Today (requires login and subscription)

Nearly Nine In 10 US Teenagers Have Been Cyberbullied, Study Finds

HealthDay (5/21, Thompson ) reports a study found that “nearly 9 of 10 teenagers have experienced cyberbullying.” According to the study’s survey of nearly 2,700 US middle- and high-school students, “the most common forms of cyberbullying reported by adolescents were mean or hurtful online comments (56%); exclusion (53%); online rumors (53%); embarrassment or humiliation (50%); repeated unwanted contact via text or online (42%); and direct threats through text or direct messages (38%).” The results indicate “that even subtle forms of cyberbullying can cause psychological harm.” Researchers said, “We were surprised to find that no single type of cyberbullying caused more harm than others; all carried a similar risk of traumatic outcomes.” The study was published in BMC Public Health.

Related Links:

— “9 In 10 U.S. Teens Have Been Cyberbullied,” Dennis Thompson, HealthDay, May 21, 2025

Foundation News

Seeking Nominations for 2022 Anti-Stigma Advocacy Award

The annual Maryland Foundation for Psychiatry (MFP) Anti-Stigma Advocacy Award recognizes a worthy piece published in a major newspaper that accomplishes one or more of the following:

  • Shares with the public their experience with mental illness in themselves, a family member, or simply in the community.
  • Helps others to overcome their inability to talk about mental illness or their own mental illness.
  • Imparts particularly insightful observations on the general subject of mental illness.

A Maryland author and/or newspaper is preferred.  Click here for past winners and published articles.

The award carries a $500 prize, which is given at the Maryland Psychiatric Society annual meeting in April.  To nominate a piece to be considered for the 2022 award, email it to mfp@mdpsych.org no later than January 10, 2022.  The article should be published during the period from January 15, 2021 to January 10, 2022.

New PSA Examines Anxiety as Pandemic Improves

As the pandemic improves and restrictions and shutdowns are lifted, many people may be experiencing anxiety at returning to the world and being amongst people. This new PSA from the Maryland Foundation for Psychiatry, Inc. examines fears people may have as they try to navigate uncertainty about going outside as well as deal with conflicting messages about how to stay safe and healthy.

Post-Pandemic AnxietyPost Pandemic Anxiety, MP3, 1.3MB

You can listen to the ad using the player in the upper right of the website’s homepage. All past public service spots are also available for listening or to download on our Radio Advertisements page.

Jamie and Sarah Raskin Recognized with Anti-Stigma Advocacy Award

Congressman Jamie Raskin and Sarah Bloom Raskin were awarded the Foundation’s 2021 Anti-Stigma Advocacy Prize for the tribute about their son, Tommy, posted on January 4, 2021. The MFP board of directors felt that it was very effective in conveying what a wonderful and gifted person their son was, that depression did not detract from this, and how painful and sad his loss and the loss of others suffering from depression can be. The board also greatly admired their courage in writing about him in such a forthright manner. The Anti-Stigma Advocacy Award was formally presented at the Maryland Psychiatric Society annual meeting on April 22.

The Foundation established this annual prize for a worthy media piece, preferably local or regional, that accomplishes one or more of the following:

  • Shares with the public their experience with mental illness in themselves, a family member, or simply in the community.
  • Helps others to overcome their inability to talk about mental illness or their own mental illness.
  • Imparts particularly insightful observations on the general subject of mental illness.

Click here for information about past winners.

Psychiatrist Weighs Taking The COVID Vaccine in New Radio Ad

Psychiatrists aren’t necessarily on the front lines treating COVID patients in a hospital, so should they take or not take a COVID vaccine? In this new ad from The Maryland Foundation for Psychiatry, Inc., one psychiatrist goes trough his thoughts as he decided whether to take it. He examines the science, the risks, possible complications, and what his decision means to his patients as well as to mental health in general.

COVID Vaccination — Why You Should Take ItCOVID Vaccination — Why You Should Take It , MP3, 1.3MB

You can listen to the ad using the player in the upper right of the website’s homepage. All past public service spots are also available for listening or to download on our Radio Advertisements page.

Political Anxiety PSA is Timely Again

As this election cycle nears election day, there is no guarantee we will know the results very soon. A combination of many factors, including a pandemic that brings its own anxiety and has seen record numbers use absentee voting and early voting to avoid crowds on election day, could cause delays in vote counts and that can add to the stress and anxiety of many people. We are featuring our PSA from 2017 which examines the wide variety of feelings people experience after a particularly divisive political campaign and things that can be done to help, ranging from breaks from Facebook and Twitter and similar sites to seeking actual help from professionals.

Listen to the PSA on our home page or on our PSA collection here, where you can listen to or download other advice given in past PSAs, also.